Collegium Pharmaceutical Inc (COLL)
Return on assets (ROA)
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Net income | US$ in thousands | 69,190 | 48,155 | -25,002 | 71,517 | 26,752 |
| Total assets | US$ in thousands | 1,663,590 | 1,143,310 | 1,174,130 | 692,077 | 643,841 |
| ROA | 4.16% | 4.21% | -2.13% | 10.33% | 4.16% |
December 31, 2024 calculation
ROA = Net income ÷ Total assets
= $69,190K ÷ $1,663,590K
= 4.16%
Based on the provided data, Collegium Pharmaceutical Inc's return on assets (ROA) has shown fluctuations over the past five years. The ROA for Collegium Pharmaceutical Inc was 4.16% as of December 31, 2020, indicating that the company generated $0.0416 in profit for every $1 of assets.
By December 31, 2021, Collegium Pharmaceutical Inc's ROA had increased significantly to 10.33%, reflecting improved efficiency in generating profits from its assets. This could be a positive sign of effective management of the company's resources.
However, the ROA took a downturn in the following year, dropping to -2.13% as of December 31, 2022. A negative ROA suggests that the company is not effectively utilizing its assets to generate profits, which could be attributed to various factors such as declining sales, increased expenses, or impairment charges.
Subsequently, by December 31, 2023, Collegium Pharmaceutical Inc managed to improve its ROA to 4.21%, showing a recovery from the previous year's performance. This improvement could indicate efforts to enhance operational efficiency and profitability.
As of December 31, 2024, the ROA remained relatively stable at 4.16%, similar to the level observed in 2020. Overall, Collegium Pharmaceutical Inc's ROA has displayed variability, highlighting the importance of monitoring and analyzing financial ratios regularly to assess the company's performance and effectiveness in utilizing its assets.
Peer comparison
Dec 31, 2024